Macquarie Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.48M | Buy |
|
|||||
|
2024
Q4 | $6.42M | Buy |
|
|||||
|
2024
Q3 | $5.29M | Sell |
|
|||||
|
2024
Q2 | $7.09M | Sell |
|
|||||
|
2024
Q1 | $13M | Sell |
|
|||||
|
2023
Q4 | $34.9M | Sell |
|
|||||
|
2023
Q3 | $41M | Buy |
|
|||||
|
2023
Q2 | $70.6M | Sell |
|
|||||
|
2023
Q1 | $93.1M | Sell |
|
|||||
|
2022
Q4 | $75.6M | Buy |
|
|||||
|
2022
Q3 | $97.2M | Buy |
|
|||||
|
2022
Q2 | $62.6M | Buy |
|
|||||
|
2022
Q1 | $67.1K | Buy |
|
|||||
|
2021
Q4 | $61.1M | Buy |
|
|||||
|
2021
Q3 | $36.9M | Buy |
|
|||||
|
2021
Q2 | $34.5M | Buy |
|
|||||
|
2021
Q1 | $92K | Sell |
|
|||||
|
2020
Q4 | $164K | Hold |
|
|||||
|
2020
Q3 | $86K | Hold |
|
|||||
|
2020
Q2 | $93K | Buy |
|